LEENO Industrial (058470) Q2 2024 earnings summary

Executive summary

• Specializes in manufacturing and selling semiconductor test probes (LEENO PIN), IC test sockets, and medical device components, with a strong export focus and proprietary technology.

• Achieved robust profitability and stable financial structure, maintaining a zero-debt policy and consistent dividend payouts.

• No subsidiaries or affiliates; all operations are consolidated within the parent company.

Financial highlights

• 2024 H1 revenue: ₩125.8B, down from ₩255.6B in 2023 and ₩322.4B in 2022 (reflecting half-year vs. full-year).

• Operating income for 2024 H1: ₩56.5B; net income: ₩50.4B; basic EPS: ₩3,324.

• Cash and cash equivalents at June 2024: ₩45.2B; total assets: ₩603.3B; equity: ₩562.1B.

• Maintained high credit rating (AA, CR-1) and strong liquidity.

Outlook and guidance

• Expects continued growth in semiconductor and medical device markets, driven by global trends in AI, 5G, and healthcare innovation.

• Plans to maintain a dividend payout ratio around 30% of net income, subject to business performance.